- 01 Jan `26This multicenter retrospective observational registry study will collect existing clinical data from Italian centers to describe epidemiology, treatment patterns, clinical evolution, safety, and comorbidities in patients aged 12 years and older wi...
Location: IRCCS Istituto Clinico Humanitas - Dermatology Unit, Rozzano, Lombardy, 20089, Italy - 23 Dec `25Building an Assessment Model for Vitiligo Activity and Prognosis Using Peripheral Blood Cytokine ProfilesOpening soonVitiligo is a chronic autoimmune disorder characterized by depigmented patches on the skin, which can pose significant psychosocial challenges, particularly for individuals with darker skin tones. Compared to the general population, individuals wi...
Location: Xijing Hospital, Xi'an, Shannxi, 710032, China - 10 Nov `25Pharos University in Alexandria plans to enroll about 30 participants. Methotrexate reduces immune activity and is being delivered through or into the skin in this study. Researchers hope it will calm the attack on melanocytes and improve repigmen...
Location: No study locations reported - 01 Nov `25translate and validate the vitiligo specific quality of life (VITIQOL) questionnaire to Arabic language. evaluate the effect of vitiligo on patient quality of life using vitiligo specific quality of life questionnaire (VitiQoL). measure the impact...
Location: No study locations reported - 01 Sep `25Dexamethasone with light therapy for vitiligoOpening soonAssiut University plans to enroll about 40 participants. The study uses controlled ultraviolet light, sometimes with an immune-modulating medicine. UV light can stimulate surviving melanocytes and may help affected skin regain color. Possible effe...
Location: No study locations reported - 01 Aug `25Crisaborole with microneedling for vitiligoOpening soonTanta University plans to enroll about 20 participants. Crisaborole is a topical PDE4 inhibitor that reduces inflammation, while microneedling may help it enter the skin. The combination may calm the local immune response and stimulate pigment ret...
Location: No study locations reported - 01 Jul `250.005% Latanoprost Gel for Nonsegmental VitiligoOpening soonLatanoprost, a prostaglandin F2α (PGF2α) analog used for glaucoma treatment, is known to cause iris darkening, hypertrichosis, and periocular skin hyperpigmentation. PGF2α has been shown to stimulate the growth of melanocyte dendrites, increasing ...
Location: Hasan Sadikin General Hospital, Bandung, West Java, 40161, Indonesia - 12 May `25Assessing the additive value of mini-oral pulse steroid therapy in surgical treatment of acral and difficult to treat sites of vitiligoWhat is being studied: drug — oral steroid-dexamethasone; procedure — non cultured epidermal suspension.Who can ...
Location: Dermatology Department, Cairo University Hospitals, Giza, 12655, Egypt - 05 Feb `25Stem-cell exosome nasal drops for vitiligoOpening soonSecond Affiliated Hospital of Wannan Medical College plans to enroll about 29 participants. This experimental treatment uses cell-derived particles and signaling proteins intended to change inflammation and tissue repair. Researchers hope these si...
Location: The Second Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, China - 01 Nov `24Dermoscopy in NailsOpening soonStudy types and frequency of nail changes in patients with vitiligocompared to healthy subjectsWhat is being studied: diagnostic test — Dermoscopy.Who can take part: ages 12 Years to 50 Years, 50 participants planned.Enrollment status: the registr...
Location: No study locations reported - 01 May `25COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGOEnrolling by invitationPatient of stable and limited vitiligo less than 20% BSA will be recruited And evaluation of efficacy and safety of narrowband UVB with topical tacrolimus vs narrowband UVB and calcipotriol will be assessedPhase: Early Phase 1.What is being studie...
Location: Lahore general.hospital, Lahore, Punjab Province, Pakistan - 01 Jan `25Efficacy and Safety of Apremilast in Combination with NBUVB and NBUVB Alone in Vitiligo PatientsEnrolling by invitationPatients of non-segmental vitiligo, fulfilling the inclusion criteria will be selected from the OPD, dermatology department. It's an interventional study where Group A patient will be given NBUVB and Tab Apremilast 30 mg twice a day and Group B wi...
Location: Dow International Medical College , DUHS, Karachi, Sindh, Pakistan - 21 Nov `24The VYN201 Gel for Vitiligo clinical trial by Vyne Therapeutics Inc. is a Phase 2 study aimed at evaluating the efficacy, safety, and pharmacokinetics of VYN201 Gel in individuals with non-segmental vitiligo. Participants will apply the gel daily ...
Location: This study has 48 locations across the U.S. and Canada - 24 May `24Although significant progress has been made in understanding vitiligo, managing the condition remains a challenge. Many treatments can achieve noticeable repigmentation (over 75%) on areas like the face and neck. However, nearly 40% of patients ex...
Location: France - 10 Apr `24The STRAVI study investigates the molecular pathways distinguishing repigmented and non-repigmented lesions in vitiligo during standard combination therapy. Using advanced transcriptomic and serum analysis, this research aims to uncover key factor...
Location: Bordeaux, France - 14 Jan `21Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia AreataEnrolling by invitationIt is a study of translational research with mechanistically objectives and including biological samples of patients with chronic inflammatory disordersWhat is being studied: biologicals — Blood samples, Skin biopsies.Who can take part: ages 18 Ye...
Location: Service de Dermatologie - Hôpital Saint-André, Bordeaux, Bordeaux, 33075, France
Seeking a Clinical Trial in Vitiligo
Clinical trials help researchers learn whether new ways to diagnose, manage, or treat vitiligo are safe and effective. They may test a medicine, light therapy, a procedure, or a combination of treatments. Some studies simply follow people over time — no experimental treatment involved.
VRF lists studies from public registries. We do not screen or recommend joining. Some sponsors contract with us for study-awareness support; those placements are disclosed when they go live. Status and sites change. Confirm them on the official record and with the research site.
If this is unfamiliar territory, start with the FAQ.
Find vitiligo studies nearby
Vitiligo Studies Recruiting Now
66 trials in total
FAQOther Questions
- Does halo nevi affect vitiligo development?
Halo nevi (also known as Sutton's nevi) are characterized by a mole that's surrounded by a ring of depigmented or lighter skin. While both halo nevi and vitiligo involve the des...
- Is it possible to stop the progression of vitiligo?
While it's not always possible to quickly stop vitiligo progression, there are some treatments that can help slow or halt the spread of the condition in many cases: Corticostero...
- How long does it take to treat vitiligo?
Vitiligo, a condition characterized by the loss of skin pigment, can be unpredictable in both progression and treatment. The time it takes to treat vitiligo varies significantly...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.